Tal Yardeni

1.4k total citations
24 papers, 948 citations indexed

About

Tal Yardeni is a scholar working on Molecular Biology, Epidemiology and Physiology. According to data from OpenAlex, Tal Yardeni has authored 24 papers receiving a total of 948 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 6 papers in Epidemiology and 6 papers in Physiology. Recurrent topics in Tal Yardeni's work include Glycosylation and Glycoproteins Research (6 papers), Inflammatory Myopathies and Dermatomyositis (5 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Tal Yardeni is often cited by papers focused on Glycosylation and Glycoproteins Research (6 papers), Inflammatory Myopathies and Dermatomyositis (5 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Tal Yardeni collaborates with scholars based in United States, Israel and United Kingdom. Tal Yardeni's co-authors include Marjan Huizing, Shelley Hoogstraten-Miller, Michael Eckhaus, H Douglas Morris, Patrick M. Schaefer, Douglas C. Wallace, Rüdiger Horstkorte, Wenke Weidemann, Stephan Hinderlich and Deborah G. Murdock and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Biochemistry and Cell Metabolism.

In The Last Decade

Tal Yardeni

23 papers receiving 943 citations

Peers

Tal Yardeni

EPIDE

PHYSI

GENET

IMMUN

Yuji Nishizawa Japan

Atsushi Hashimoto Japan

Ly Q. Hong‐Brown United States

Annick You-Ten Canada

Giulio Kleiner United States

Itaru Toyoshima Japan

Qingning Su United States

Xiaobo Xia China

Paloma B. Liton United States

Yuji Nishizawa Japan

Tal Yardeni

883 ×1.8

95 ×0.6

EPIDE

124 ×0.9

PHYSI

76 ×0.7

GENET

67 ×0.6

IMMUN

Citations per year, relative to Tal Yardeni Tal Yardeni (= 1×) peers Yuji Nishizawa

Countries citing papers authored by Tal Yardeni

Since Specialization

Citations

This map shows the geographic impact of Tal Yardeni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tal Yardeni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tal Yardeni more than expected).

Fields of papers citing papers by Tal Yardeni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tal Yardeni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tal Yardeni. The network helps show where Tal Yardeni may publish in the future.

Co-authorship network of co-authors of Tal Yardeni

This figure shows the co-authorship network connecting the top 25 collaborators of Tal Yardeni. A scholar is included among the top collaborators of Tal Yardeni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tal Yardeni. Tal Yardeni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Passini, Fabian S., Yael Kuperman, Sharon Krief, et al.. (2025). Piezo2 in sensory neurons regulates systemic and adipose tissue metabolism. Cell Metabolism. 37(4). 987–1000.e6. 2 indexed citations

Levy‐Shraga, Yael, Inessa Grinberg, Sylvie Polak‐Charcon, et al.. (2025). Clinical, biochemical and cell biological characterization of KIDAR syndrome associated with a novel AP1B1 variant. Molecular Genetics and Metabolism. 144(4). 109056–109056.

Yardeni, Tal, Hsiao‐Wen Chen, Liqing Wang, et al.. (2025). Mitochondrial DNA lineages determine tumor progression through T cell reactive oxygen signaling. Proceedings of the National Academy of Sciences. 122(1). e2417252121–e2417252121. 5 indexed citations

Meir, Amilia, Orit Itzhaki, Liat Shbiro, et al.. (2024). Improved CAR-T cell activity associated with increased mitochondrial function primed by galactose. Leukemia. 38(7). 1534–1540. 6 indexed citations

Schaefer, Patrick M., et al.. (2022). Nicotinamide riboside alleviates exercise intolerance in ANT1-deficient mice. Molecular Metabolism. 64. 101560–101560. 12 indexed citations

Huizing, Marjan, Tal Yardeni, Federico Fuentes, et al.. (2019). Rationale and Design for a Phase 1 Study of N-Acetylmannosamine for Primary Glomerular Diseases. Kidney International Reports. 4(10). 1454–1462. 7 indexed citations

Yardeni, Tal, Ceylan Tanes, Kyle Bittinger, et al.. (2019). Host mitochondria influence gut microbiome diversity: A role for ROS. Science Signaling. 12(588). 124 indexed citations

Yardeni, Tal, Noga Kozer, Shir Nevo, et al.. (2018). High content image analysis reveals function of miR-124 upstream of Vimentin in regulating motor neuron mitochondria. Scientific Reports. 8(1). 59–59. 26 indexed citations

Hinderlich, Stephan, Wenke Weidemann, Tal Yardeni, Rüdiger Horstkorte, & Marjan Huizing. (2013). UDP-GlcNAc 2-Epimerase/ManNAc Kinase (GNE): A Master Regulator of Sialic Acid Synthesis. Topics in current chemistry. 366. 97–137. 84 indexed citations

10.

Yardeni, Tal, Justin Poling, Carla Ciccone, et al.. (2012). The Gne M712T Mouse as a Model for Human Glomerulopathy. American Journal Of Pathology. 180(4). 1431–1440. 25 indexed citations

11.

Yardeni, Tal, Terren K. Niethamer, Carla Ciccone, et al.. (2012). Murine isoforms of UDP-GlcNAc 2-epimerase/ManNAc kinase: Secondary structures, expression profiles, and response to ManNAc therapy. Glycoconjugate Journal. 30(6). 609–618. 3 indexed citations

12.

Niethamer, Terren K., Tal Yardeni, Petcharat Leoyklang, et al.. (2012). Oral monosaccharide therapies to reverse renal and muscle hyposialylation in a mouse model of GNE myopathy. Molecular Genetics and Metabolism. 107(4). 748–755. 38 indexed citations

13.

Yardeni, Tal, Michael Eckhaus, H Douglas Morris, Marjan Huizing, & Shelley Hoogstraten-Miller. (2011). Retro-orbital injections in mice. Lab Animal. 40(5). 155–160. 377 indexed citations

14.

Yardeni, Tal, Carla Ciccone, Yair Anikster, et al.. (2011). Identification, Tissue Distribution, and Molecular Modeling of Novel Human Isoforms of the Key Enzyme in Sialic Acid Synthesis, UDP-GlcNAc 2-Epimerase/ManNAc Kinase. Biochemistry. 50(41). 8914–8925. 25 indexed citations

15.

Nemunaitis, Gregory, Chris Jay, Phillip B. Maples, et al.. (2011). Hereditary Inclusion Body Myopathy: Single Patient Response to Intravenous Dosing of GNE Gene Lipoplex. Human Gene Therapy. 22(11). 1331–1341. 36 indexed citations

16.

Shapiro, Rivka, Yair Anikster, Tal Yardeni, et al.. (2010). DHPLC screening for mutations in progressive familial intrahepatic cholestasis patients. Journal of Human Genetics. 55(5). 308–313. 5 indexed citations

17.

Kurochkina, Natalya, Tal Yardeni, & Marjan Huizing. (2009). Molecular modeling of the bifunctional enzyme UDP-GlcNAc 2-epimerase/ManNAc kinase and predictions of structural effects of mutations associated with HIBM and sialuria. Glycobiology. 20(3). 322–337. 21 indexed citations

18.

Bercovich, Dani, Tal Yardeni, Joël Zlotogora, et al.. (2008). A Mutation Analysis of the Phenylalanine Hydroxylase (PAH) Gene in the Israeli Population. Annals of Human Genetics. 72(3). 305–309. 23 indexed citations

19.

Bercovich, Dani, Joël Zlotogora, Tal Yardeni, et al.. (2008). Genotype–phenotype correlations analysis of mutations in the phenylalanine hydroxylase (PAH) gene. Journal of Human Genetics. 53(5). 407–418. 36 indexed citations

20.

Epelbaum, Ron, et al.. (1999). Phase II study of gemcitabine (GEM) combined with radiation therapy (RT) in localized, unresectable pancreatic cancer. European Journal of Cancer. 35. S148–S149. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact